British nanomaterials application developer Oxonica has suffered another string of setbacks, leaving the firm slouching towards collapse. It recently announced plans to de-list from London's Alternative Investment Market (AIM), likely...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)